wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q46972620-5FF3E057-843C-4B05-8A79-6C7FA9994D9A
Q46972620-5FF3E057-843C-4B05-8A79-6C7FA9994D9A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46972620-5FF3E057-843C-4B05-8A79-6C7FA9994D9A
Rome Foundation Endpoints and Outcomes Conference 2009: Optimizing Clinical Trials in FGID.
P2860
Q46972620-5FF3E057-843C-4B05-8A79-6C7FA9994D9A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46972620-5FF3E057-843C-4B05-8A79-6C7FA9994D9A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f88600ea514f624aec77a30c2ee66306018b5821
P2860
A phase II trial of the novel serotonin type 3 receptor antagonist ramosetron in Japanese male and female patients with diarrhea-predominant irritable bowel syndrome.